Posts for the 'Defective Products' Category
Vytorin cancer side effects evaluated by FDA
The FDA released an early communication yesterday about an ongoing safety review of Vytorin, Zetia and Zocor, and a possible association with the development of cancer. Vytorin users were found to have a higher incidence of cancer in a small study that was recently released, and the FDA indicates that they will be reviewing data from this study over the next nine months before reaching any formal conclusions about whether there is a causal relationship between the drugs and this emerging safety issue.
>>FDA LINK: Vytorin, Zetia and Zocor Early Communication
Byetta Pancreatitis Lawsuit Evaluations
The product liability lawyers at Saiontz, Kirk & Miles, P.A. are now reviewing and evaluating potential Byetta lawsuits for individuals diagnosed with pancreatitis after receiving the type 2 diabetes injection to help lower their blood glucose levels. Byetta has been associated with a number of reports of acute pancreatitis, hemorrhagic pancreatitis and necrotizing pancreatitis.
Fosamax Lawsuits Continue to Pile Up Against Merck
According to a report published last week by Lloyds Corporate Litigation Reporter, Merck & Co., Inc. faced approximately 655 Fosamax lawsuits involving over 1,000 plaintiff groups as of June 30, 2008. The lawsuits were filed on behalf of users who have suffered a disfiguring jaw condition, known as osteonecrosis of the jaw, and other side effects related to the oosteoporosis drug.
>>INFORMATION: Fosamax Lawsuits
Byetta Pancreatitis Risk Highlighted by FDA
The FDA has issued another warning to doctors about reports of users of Byetta developing pancreatitis. Following an earlier alert issued in October 2007, the FDA indicates that they have received at least six new cases of hemorrhagic pancreatitis or necrotizing pancreatitis associated with Byetta side effects. Two of these cases resulted in death.
>>PRIOR POST (10/17/2007): Byetta Pancreatitis Side Effects
Digoxin Lawsuit Consolidation in West Virginia
Last week the United States Judicial Panel on Multidistrict Litigation ordered that any individual Digoxin lawsuit filed as a result of the April 2008 Digitek recall should be transferred to the Southern District of West Virginia. All cases will be consolidated for pretrial litigation and discovery before Judge Joseph R. Goodwin.
Shoulder Pain Pump Chondrolysis Lawsuits: MDL Petition Denied
The United States Judicial Panel on Multidistrict Litigation has denied a motion to consolidate all shoulder pain pump chondrolysis lawsuits that have been filed in federal court. Therefore, the pain pump litigation will not be centralized and lawsuits that have been filed by individuals diagnosed with postarthroscopic glenohumeral chondrolysis will have their cases remain in the jurisdiction where they were filed.
Boston Scientific Carotid Stent Recall
Boston Scientific has issued a class 1 recall for their NexStent Monorail, NexStent Carotid Stent and Monorail Delivery System due to a defect which could allow the tip of the stent delivery system to detach while it is being implanted. This could pose a risk of serious and potentially fatal injury.
>>FDA LINK: Boston Scientific Stent Recall
Generic Fentanyl Pain Patch Recall
For the fourth time this year, a generic fentanyl pain patch recall was issued because some patches have been found to be leaking fentanyl gel, which could cause a fentanyl overdose or death. The latest recall was issued by Watson Pharmaceuticals, Inc. for one lot of their 75 mcg/hr Fentanyl Transdermal System pain patches, which were sold throughout the United States.
>>INFORMATION: Fentanyl Pain Patch Lawsuits
Zimmer Durom Cup Class Action Lawsuit
On July 22, 2008, Zimmer announced that they were suspending sales of their Durom Cup hip implant due to an unusually high number of reported failures and hip revisions. While our product liability lawyers at Saiontz, Kirk & Miles, P.A. are reviewing individual Zimmer lawsuits on behalf of individuals who have suffered injuries, the first Zimmer class action suit was filed in federal court on behalf of shareholders who claim that the company’s failure to disclose the Durom Cup problems caused a sudden drop in the price of their stock.
Baltimore Medicine Shoppe Lawsuits: Expired and Counterfeit Drugs
Late Friday, the FDA posted a warning to Baltimore residents who filled prescriptions at two Medicine Shoppe pharmacies. Expired drugs and potentially counterfeit medications could have been distributed by the Baltimore pharmacy. The lawyers at Saiontz, Kirk & Miles, P.A., who are based in Baltimore, Maryland, are evaluating potential lawsuits on behalf of customers who suffered severe injuries or reactions to the medications.
>>INFORMATION: Pharmacy Mistake Lawsuits
